| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $289.0M | +6.4% | +22.5% |
| Cost of Revenue | $124.5M | +3.9% | +17.8% |
| Gross Profit | $164.4M | +8.3% | +26.3% |
| R&D Expense | $69.0M | +3.8% | +19.3% |
| SG&A Expense | $44.6M | +6.2% | +19.1% |
| Operating Income | $50.8M | +17.4% | +45.8% |
| Pre-tax Income | $56.9M | +14.8% | +39.1% |
| Income Tax | $10.6M | +1188.6% | +14.3% |
| Net Income | $46.3M | -5.0% | +46.3% |
| EPS (Basic) | $0.62 | -4.6% | +44.2% |
| EPS (Diluted) | $0.60 | -6.3% | +42.9% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $98.5M | -17.7% | -11.2% |
| Short-term Investments | $566.3M | -12.7% | -0.7% |
| Accounts Receivable | $159.6M | -0.3% | +21.5% |
| Inventory | $252.2M | +5.6% | +20.5% |
| Current Assets | $1.13B | -6.6% | +5.8% |
| Total Assets | $2.01B |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $121.6M | +183.3% | — |
| Capital Expenditures | $26.1M | +102.0% | — |
| Investing Cash Flow | $73.5M | +738.6% | — |
| Financing Cash Flow | -$208.7M | -372.2% | — |
| Free Cash Flow | $95.5M | +218.3% | — |
| +5.0% |
| Current Liabilities | $149.7M | -50.8% | -49.9% |
| Long-term Debt | $340.2M | +0.1% | +0.3% |
| Total Liabilities | $596.8M | -20.7% | -16.7% |
| Stockholders' Equity | $1.42B | +4.8% | +17.9% |